Browse Prescribing Notes by Therapeutic Subcategory

Recombinant cytokines activate the immune system to recognize and eliminate certain kinds of cancer cells. Interferons bind to specific cell-surface receptors that initiate a series of intracellular events including inhibition of cell proliferation. Aldesleukin activates T-cells and NK (natural killer) cells to help attack and destroy cancerous tumors.